Profile data is unavailable for this security.
About the company
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
- Revenue in JPY (TTM)159.27bn
- Net income in JPY19.99bn
- Incorporated1944
- Employees2.80k
- LocationHisamitsu Pharmaceutical Co Inc30F, Marunouchi Bldg., 2-4-1, MarunouchiCHIYODA-KU 100-6330JapanJPN
- Phone+81 352931700
- Fax+81 352931750
- Websitehttps://www.hisamitsu.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kyorin Pharmaceutical Co Ltd | 133.26bn | 10.77bn | 99.87bn | 2.00k | 8.89 | 0.6892 | 6.49 | 0.7495 | 187.40 | 187.40 | 2,319.59 | 2,417.37 | 0.6927 | 1.08 | 2.93 | 66,695,200.00 | 5.60 | 3.34 | 7.03 | 4.16 | 45.32 | 45.89 | 8.08 | 5.11 | 2.05 | -- | 0.1746 | 57.34 | 8.83 | 3.41 | 70.73 | 8.12 | 14.36 | -7.06 |
| Katakura Industries Co Ltd | 40.98bn | 5.84bn | 106.53bn | 941.00 | 16.59 | 1.06 | 12.11 | 2.60 | 182.30 | 182.30 | 1,278.51 | 2,853.06 | 0.2926 | 2.15 | 6.42 | 43,545,160.00 | 4.27 | 2.60 | 5.20 | 3.57 | 36.16 | 37.98 | 14.59 | 9.44 | 2.63 | -- | 0.0807 | 23.42 | -1.37 | -2.19 | 15.73 | 15.27 | -7.22 | 33.03 |
| Zeria Pharmaceutical Co Ltd | 86.61bn | 7.26bn | 113.33bn | 1.75k | 13.45 | 1.02 | 7.79 | 1.31 | 164.79 | 164.79 | 1,964.97 | 2,178.21 | 0.5366 | 1.27 | 3.21 | 49,607,640.00 | 4.49 | 4.67 | 6.99 | 7.47 | 72.76 | 72.17 | 8.37 | 9.02 | 0.9739 | 11.41 | 0.2984 | 28.75 | 15.30 | 7.64 | 28.52 | 27.71 | 16.51 | 6.69 |
| Mochida Pharmaceutical Co Ltd | 111.92bn | 6.42bn | 135.73bn | 1.51k | 20.59 | 0.9621 | 14.46 | 1.21 | 181.16 | 181.16 | 3,156.95 | 3,876.77 | 0.6427 | 1.67 | 3.02 | 74,214,190.00 | 3.69 | 4.50 | 4.47 | 5.44 | 48.43 | 52.49 | 5.74 | 6.87 | 2.85 | -- | 0.0678 | 43.01 | 2.21 | 0.6516 | 25.03 | 4.34 | 1.98 | 0.00 |
| Kaken Pharmaceutical Co Ltd | 75.66bn | -3.83bn | 186.49bn | 1.13k | -- | 1.10 | -- | 2.46 | -97.11 | -97.11 | 1,980.56 | 3,850.39 | 0.4091 | 1.86 | 2.80 | 67,195,380.00 | -2.07 | 5.99 | -2.42 | 6.87 | 53.09 | 56.17 | -5.06 | 12.91 | 3.21 | -- | 0.0257 | 59.58 | 30.52 | 1.05 | 73.77 | -6.36 | 14.81 | 0.00 |
| Towa Pharmaceutical Co Ltd | 269.92bn | 21.44bn | 191.64bn | 4.79k | 8.54 | 0.9654 | 4.40 | 0.71 | 435.61 | 435.61 | 5,483.17 | 3,853.29 | 0.5695 | 1.49 | 3.37 | 56,374,690.00 | 4.52 | 3.89 | 5.53 | 5.07 | 36.72 | 37.81 | 7.94 | 6.61 | 1.54 | 32.77 | 0.5519 | 21.52 | 13.89 | 18.65 | 17.39 | 5.53 | 46.23 | 9.73 |
| Kissei Pharmaceutical Co Ltd | 95.29bn | 14.14bn | 216.42bn | 1.78k | 13.78 | 0.8908 | 11.46 | 2.27 | 337.47 | 337.47 | 2,274.29 | 5,220.29 | 0.3748 | 1.85 | 2.83 | 53,596,180.00 | 5.62 | 4.26 | 6.19 | 4.60 | 48.21 | 48.59 | 14.99 | 14.30 | 3.42 | -- | 0.0058 | 32.41 | 16.87 | 6.91 | 7.18 | 33.54 | 31.04 | 13.97 |
| Sawai Group Holdings Co Ltd | 200.68bn | -1.25bn | 264.52bn | 3.31k | -- | 1.48 | 18.31 | 1.32 | -9.86 | -22.64 | 1,734.07 | 1,548.25 | 0.5445 | 1.28 | 3.40 | 60,628,400.00 | -0.3389 | -0.2327 | -0.4542 | -0.3187 | 28.89 | 32.95 | -0.6224 | -0.475 | 1.08 | -1.04 | 0.4066 | 191.65 | 6.88 | 0.7009 | -87.38 | -35.38 | 8.65 | 4.11 |
| Tsumura & Co | 189.50bn | 29.01bn | 310.79bn | 4.27k | 10.46 | 0.9885 | 7.29 | 1.64 | 387.15 | 387.15 | 2,524.84 | 4,095.99 | 0.374 | 0.7106 | 2.41 | 44,357,680.00 | 6.01 | 5.53 | 8.06 | 6.85 | 47.60 | 49.39 | 16.06 | 14.50 | 1.45 | -- | 0.2856 | 31.65 | 20.05 | 8.00 | 94.10 | 18.69 | 23.07 | 16.27 |
| Nippon Shinyaku Co Ltd | 166.05bn | 29.85bn | 349.71bn | 2.24k | 11.23 | 1.18 | 9.66 | 2.11 | 443.17 | 443.17 | 2,465.26 | 4,211.80 | 0.5421 | 1.17 | 3.19 | 74,028,980.00 | 9.75 | 10.89 | 10.81 | 12.74 | 67.29 | 63.93 | 17.98 | 17.67 | 4.04 | -- | 0.0089 | 30.58 | 8.08 | 6.56 | 25.94 | 14.06 | 80.48 | 7.59 |
| Hisamitsu Pharmaceutical Co Inc | 159.27bn | 19.99bn | 465.27bn | 2.80k | 22.35 | 1.61 | 16.90 | 2.92 | 276.99 | 276.99 | 2,208.13 | 3,837.32 | 0.4704 | 2.64 | 3.42 | 56,901,390.00 | 6.04 | 4.34 | 7.25 | 4.99 | 59.05 | 57.83 | 12.84 | 10.32 | 3.28 | -- | 0.0086 | 50.29 | 10.09 | 2.04 | 55.76 | 3.08 | 29.89 | 0.7127 |
| Santen Pharmaceutical Co Ltd | 287.99bn | 30.60bn | 554.31bn | 3.85k | 18.69 | 1.95 | 11.38 | 1.92 | 92.03 | 92.03 | 865.27 | 880.97 | 0.7205 | 2.26 | 4.18 | 74,823,070.00 | 7.63 | 3.94 | 9.43 | 4.93 | 56.89 | 58.97 | 10.59 | 6.01 | 1.89 | -- | 0.1757 | 71.86 | -0.6494 | 4.43 | 36.09 | 8.94 | 3.61 | 5.92 |
| Rohto Pharmaceutical Co Ltd | 335.80bn | 34.48bn | 593.75bn | 9.14k | 16.95 | 1.98 | 11.41 | 1.77 | 148.28 | 148.28 | 1,444.67 | 1,272.14 | 0.7768 | 2.32 | 4.55 | 36,723,640.00 | 8.02 | 8.59 | 11.20 | 11.70 | 56.06 | 57.78 | 10.33 | 10.57 | 1.43 | -- | 0.1452 | 21.12 | 13.95 | 10.38 | 0.2263 | 15.01 | 10.42 | 22.59 |
Data as of Feb 16 2026. Currency figures normalised to Hisamitsu Pharmaceutical Co Inc's reporting currency: Japanese Yen JPY
10.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 2.00m | 2.66% |
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 1.39m | 1.84% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 1.17m | 1.56% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 715.80k | 0.95% |
| Amova Asset Management Co., Ltd.as of 06 Feb 2026 | 681.40k | 0.91% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 619.70k | 0.82% |
| Goldman Sachs Asset Management LPas of 31 Oct 2025 | 587.30k | 0.78% |
| Dimensional Fund Advisors LPas of 31 Jan 2026 | 372.30k | 0.50% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 22 Jul 2024 | 277.90k | 0.37% |
| Charles Schwab Investment Management, Inc.as of 05 Feb 2026 | 196.70k | 0.26% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
